6 reports

THE COMPANY S PORTFOLIO INCLUDES BIOLOGICAL AND CHEMICAL MEDICINES AND ORIGINAL PRODUCTS, PARTICULARLY FOR THE TREATMENT OF CANCERS AND AUTOIMMUNE DISEASES.

  • Cardiac Management
  • Eastern Europe
  • Russia
  • Market Size
  • Boston Scientific Corporation

With the change in lifestyle, people worldwide are more prone to disorders such as obesity, autoimmune diseases, and cardiovascular problems.

  • Cardiac Management
  • Boston Scientific Corporation
  • GE Healthcare Limited
  • Jude Medical, Inc.
  • Medtronic, Inc.

(SetPoint Medical) is a biotechnology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases.

  • Cardiac Management
  • Cardiology
  • United States
  • M&A
  • Boston Scientific Corporation

In addition to transplantation, IdeS is being evaluated in a clinical Phase II study in the rare autoimmune disease anti-GBM antibody disease and IdeS has potential applications in a variety of additional autoimmune diseases.

  • Cardiac Management
  • Healthcare
  • North America
  • United States
  • Market Size

THE MAIN TARGETS FOR CELL-BASED THERAPIES ARE HIGH IMPACT DISEASE AREAS WITH SIGNIFICANT UNMET NEED, INCLUDING CANCER, HEART DISEASE, NEURODEGENERATIVE DISEASES, MUSCULOSKELETAL DISORDER AND AUTOIMMUNE DISEASES.

  • Cardiac Management
  • Northern Europe
  • United Kingdom
  • Forecast
  • Market Size

The main targets for cell-based therapies are high impact disease areas with significant unmet need, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorder and autoimmune diseases.

  • Cardiac Management
  • Canada
  • North America
  • Forecast
  • Market Size